Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC
Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies
SIOG 2024: Updates in radiation oncology
SIOG 2024: Updates in medical oncology
Patterns and correlates of multiple tobacco product use among people with HIV in India
Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia
Understanding Rwanda's FDA and its role in medicine regulation
Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma
High-fibre dietary intervention in precursor plasma cell disorders improves biomarkers of disease, may delay progression to myeloma
Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer
The use of IORT at L'Hospitalet de Llobregat
The use of IORT at Montefiore Medical Center